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Visible Light Photoredox Catalysis Enables the Biomimetic 
Synthesis of Nyingchinoids A, B and D, and Rasumatranin D 
Jacob D. Hart, Laura Burchill, Aaron J. Day, Christopher G. Newton, Christopher J. Sumby, David M. 
Huang and Jonathan H. George* 
Abstract: The total synthesis of nyingchinoids A and B has been 
achieved via successive rearrangements of a 1,2-dioxane 
intermediate that was assembled using a visible light photoredox 
catalysed aerobic [2+2+2] cycloaddition. Nyingchinoid D was 
synthesised by a competing [2+2] cycloaddition. Based on NMR 
data and biosynthetic speculation, we proposed a structure revision 
of the related natural product rasumatranin D, which was confirmed 
through total synthesis. Under photoredox conditions, we observed 
the conversion of a cyclobutane into a 1,2-dioxane via retro-[2+2] 
cycloaddition followed by aerobic [2+2+2] cycloaddition. 
The renaissance of visible light photoredox catalysis during 
the past decade has significantly enhanced the toolkit of organic 
synthesis through the improved ability to access radicals and 
radical ions under mild conditions.1 However, the application of 
photoredox catalysis to the total synthesis of natural products 
has been relatively slow, with most examples to date involving 
the reductive generation of alkyl radicals or photocatalysed [4+2] 
and [2+2] cycloadditions.2 Herein, we report the first total 
synthesis application of a photocatalytic aerobic [2+2+2] 
cycloaddition as the key step of a biomimetic route to 
nyingchinoid3 and rasumatranin4 meroterpenoid natural products.  
   
Scheme 1. Proposed biosynthesis of nyingchinoids A, B and D.  
Nyingchinoids A-H are a family of polycyclic meroterpenoids 
isolated from Rhododendron nyingchiense by Hou and co-
workers, with each natural product identified as a scalemic 
mixture by chiral HPLC.3 We were particularly interested in the 
biosynthetic relationships between nyingchinoids A (1), B (2) 
and D (3) and a possible biosynthetic precursor, chromene 4 
(Scheme 1). While nyingchinoid D (3) is most likely derived from 
an intramolecular, photochemical [2+2] cycloaddition of 4, the 
biosynthetic origin of nyingchinoids A (1) and B (2) is less 
obvious. We propose that 1,2-dioxane 5 is an undiscovered 
natural product or biosynthetic intermediate that links chromene 
4 to 1 and 2. The 1,2-dioxane 5 could arise via a [2+2+2] 
cycloaddition between oxygen and the chromene and prenyl 
alkenes of 4. Intramolecular dearomatization of 5 driven by 
cleavage of the weak O-O bond could then form 2.5 Nucleophilic 
attack at the epoxide of 2 by the newly formed tertiary alcohol 
could then rearomatize the system via an unusual C-C bond 
scission to give 1. 
In biosynthesis, the aerobic [2+2+2] cycloaddition has only 
been proposed to occur in the formation of gracilioethers A and 
H,6 although this reaction has not been successfully applied in a 
total synthesis of these,7 or any other, 1,2-dioxane natural 
products. The majority of 1,2-dioxane natural products are 
biosynthesised via [4+2] cycloadditions between 1,3-dienes (of 
either terpene or polyketide origin) and singlet oxygen, a 
reaction that is amenable to biomimetic synthesis.8 The 
biomimetic synthesis of 1,2-dioxane natural products has also 
been achieved using cascade radical cyclizations that 
incorporate triplet oxygen.9  
As a synthetic method, the photocatalytic aerobic [2+2+2] 
cycloaddition of electron-rich 1,1-disubstituted styrenes to give 
1,2-dioxanes using 9,10-dicyanoathracene (DCA) as the 
photocatalyst was first reported by Gollnick.10 Synthesis of 
bicyclic endoperoxides via aerobic [2+2+2] cycloaddition of 
electron-rich bis(styrene) substrates was later disclosed by 
Miyashi, again using DCA as the photocatalyst.11 More recently, 
the scope of the aerobic [2+2+2] cycloaddition was significantly 
extended by Yoon to include less electron-rich bis(styrene) 
substrates using Ru(bpz)32+ as an efficient photocatalyst.12 Most 
recently, and most relevantly to this work, Nicewicz showed that 
the use of triarylpyrylium salts as organic photocatalysts allowed 
the aerobic [2+2+2] cycloaddition of dienes bearing one styrene 
and one aliphatic alkene (Scheme 2).13  
  
Scheme 2. Nicewicz’s photocatalysed cyclization-endoperoxidation cascade 
of a tethered diene using a triarylpyrylium catalyst. 4-MeO-TPT = 2,4,6-tris(4-
methoxyphenyl)pyrylium tetrafluoroborate. 
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Scheme 3. Biomimetic synthesis of nyingchinoids A, B and D. TBSCl = tert-butyldimethylsilyl chloride, DMF = N,N-dimethylformamide, DCE = 1,2-dichloroethane, 
TBAF = tetra-n-butylammonium fluoride, THF = tetrahydrofuran.  
Our biomimetic synthesis of nyingchinoids A, B and D is 
outlined in Scheme 3. Racemic chromene 4 was first 
synthesised in one step by condensation of orcinol with citral 
according to a known procedure.14 We then attempted to convert 
chromene 4 into 1,2-dioxane 5 using various oxidation protocols. 
Firstly, exposure of 4 to conditions known to generate singlet 
oxygen (e.g. Rose Bengal sensitiser, O2, MeOH, visible light) 
gave products exclusively formed by oxidation of the prenyl side 
chain, rather than the electron-rich chromene.15 Secondly, 
attempts to oxidise 4 to a phenoxy radical in the presence of O2 
resulted in degradation of starting material.16 We therefore 
protected 4 as TBS-ether 6, which we thought could be oxidised 
to a radical cation under photoredox conditions. Treatment of 6 
with a slightly modified version of Nicewicz’s conditions for 
pyrylium photoredox catalysed aerobic [2+2+2] cycloaddition (2 
mol% 4-MeO-TPT photocatalyst, DCE, 0 °C, 1 atm O2, 470 nm 
LED) gave, after 20 min, cyclobutane 8 as the only product 
observed in crude 1H NMR spectrum of the reaction mixture.17 
After purification, 8 was obtained in 87% yield. Deprotection of 8 
using TBAF in THF gave nyingchinoid D (3) in 86% yield. 
However, on repeating this [2+2] cycloaddition we noticed the 
gradual formation of the desired 1,2-dioxane 7 (as a single 
diastereoisomer) when the reaction was run for extended time 
periods. After 7 h, 7 was obtained in 60% yield. No reaction was 
observed in either the absence of photocatalyst or blue LED light. 
Treatment of 7 with TBAF formed nyingchinoid B (2) in 92% 
yield via intramolecular dearomatization of the intermediate 
phenoxide anion.18 Acid catalysed rearrangement of 2 using 
TFA in CH2Cl2 then gave nyingchinoid A (1) in 58% yield. Next, 
we investigated some telescoped reactions of chromene 6 to 
form 1 and 2 in one-pot procedures. Pleasingly, photoredox 
catalysed aerobic [2+2+2] cycloaddition of 6 followed by addition 
of TBAF gave 2 in 61% yield, while addition of TBAF followed by 
TFA gave 1 in 53% yield. The latter transformation of 6 into 1 
involves the construction of 2 rings, 3 stereocentres, 4 C-O 
bonds and 1 C-C bond, alongside the scission of 1 O-O bond 
and 1 C-C bond.  
Our experimental results clearly demonstrate that the 
photoredox catalyzed [2+2] cycloaddition of 6 is reversible using 
the 4-MeO-TPT photocatalyst. Indeed, re-subjecting cyclobutane 
8 to this catalyst under aerobic conditions formed 1,2-dioxane 7 
in 71% yield, with inversion of the relative configuration at C-11 
indicating that full cycloreversion had taken place before the 
[2+2+2] cycloaddition. In previous studies of photocatalytic, 
intermolecular [2+2] cycloadditions of electron-rich styrenes, 
Yoon has observed significant cycloreversion of the cyclobutane 
products when using the highly oxidizing photocatalyst 
Ru(bpz)32+.19 A mechanistic cycle for the aerobic [2+2+2] 
cycloaddition of 6 that incorporates a reversible [2+2] 
cycloaddition is outlined in Scheme 4. The 4-MeO-TPT 
photocatalyst is first activated by blue LED light to give an 
excited state capable of oxidizing the electron-rich chromene 6 
to give radical cation 9. 5-exo-trig cyclization of 9 generates the 
diasteromeric, distonic radical cations 10 and 12. Diastereomer 
10 has the correct relative configuration to undergo further 
cyclization to give the cyclobutane radical cation 11, followed by 
reduction to give cyclobutane 8 as the overall kinetic product of 
the reaction. Diastereomer 12 is unable to undergo reductive 
cyclization in this manner, so it is trapped by 3O2 to give 14 via 
the peroxy radical cation 13. Single electron reduction of 13 then 
gives 1,2-dioxane 7 as the thermodynamic product. Re-oxidation 
of 8 by the excited photocatalyst could regenerate radical cation 
9 via retro-[2+2] cycloaddition of 11, thus allowing the kinetic 
product 8 to be “recycled” to give 7 via radical cation 12. The 
high oxidation potential of the excited state of 4-MeO-TPT+ 
(+1.74 V) is presumably required to oxidize 8 prior to 
cycloreversion. This stepwise mechanistic pathway is supported 
by computational modeling using density functional theory, 
which shows that both 5-exo-trig cyclizations of radical cation 9 
are reversible and confirms 7 as the thermodynamic product, but 
indicates that the system becomes kinetically trapped as 11 
instead of forming 12 (see the Supporting Information for full 
details). 





     
Scheme 4. Proposed mechanistic cycle for the photocatalysed cyclization of chromene 6 to give 1,2-dioxane 7 and cyclobutane 8.  
Finally, we compared the NMR spectra of nyingchinoid A (1), 
whose structure has been unequivocably proven by X-ray 
crystallography, with that of the related natural product 
rasumatranin D, which suggested that the previously proposed 
structure 15 was incorrect (Figure 1).4 We believed that the 
substitution pattern of the aromatic ring and the relative 
configuration at C-11 of rasumatranin D should be reassigned as 
structure 16, in line with the structure of nyingchinoid A. The 
coupling constant of 14 Hz between H-3 and H-11, and the 
absence of an nOe interaction, indicates a trans relationship at 
this ring junction of 16. Furthermore, the co-isolation of the 
cyclobutane natural product 17 alongside rasumatranin D 
suggested a common chromene biosynthetic precursor with the 
same aromatic substitution pattern as the nyingchinoids.20 
     
Figure 1. Proposed structure revision of rasumatranin D.  
Our synthesis of the revised rasumatranin D structure 16 is 
outlined in Scheme 5. Firstly, 18 was synthesised by TBS-
protection of a known chromene.21 Visible light photoredox 
catalysed aerobic [2+2+2] cycloaddition of 18 then gave 1,2-
dioxane 19. Treatment of 19 with TBAF formed the nyingchinoid 
B analogue 20 (presumably an undiscovered natural product), 
which gave rasumatranin D (16) on exposure to TFA. NMR data 
for 16 showed excellent agreement with the published data for 
natural rasumatranin D, thus confirming the structure revision. 
The synthesis of rasumatranin D was significantly streamlined 
by conducting a one-pot conversion of 18 into 16 in 49% yield.  
 
Scheme 5. Biomimetic synthesis of rasumatranin D. 
In conclusion, we have achieved the biomimetic synthesis of 
nyingchinoids A, B and D, and the revised structure of 
rasumatranin D, using [2+2] and [2+2+2] cycloadditions that 
were initiated by oxidation of electron-rich chromenes. The use 
of visible light mediated photoredox catalysis to oxidize these 
substrates enabled the cycloadditions to be telescoped with 
further rearrangements in multi-step, one-pot procedures. The 
predisposed, highly diastereoselective, biomimetic synthesis of 
nyingchinoids A and B from a common chromene intermediate 
gives good insight into the biosynthesis of these natural products, 
which is supported by the structure revision of rasumatranin D. 
Furthermore, we observed for the first time the synthesis of a 





1,2-dioxane from a cyclobutane via a photocatalysed retro-[2+2] 
cycloaddition / aerobic [2+2+2] cycloaddition cascade reaction. 
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